News Agency
Men's Weekly

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

  • Written by PR Newswire
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical characterization step in the candidate development process to ensure drug efficacy and...

Read more: Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

Why Headless CMS Fits Naturally Into Modern DevOps Pipelines

Modern DevOps pipelines are about speed, reliability, automation, and continuous development. Teams want to deploy small changes frequently instead of large changes less frequently, minimizing risk with isolating changes and maintaining visibility into a complex system. Traditional CMS solutions do... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion